BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21131914)

  • 1. Neuro-oncology: Genetic variation in pediatric and adult brain tumors.
    Brandes AA; Franceschi E
    Nat Rev Neurol; 2010 Dec; 6(12):653-4. PubMed ID: 21131914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of the genomic landscape of common pediatric CNS tumors and how data sharing will continue to shape this landscape in the future.
    Kaneva K; Goldman S
    Mol Biol Rep; 2021 Nov; 48(11):7537-7544. PubMed ID: 34643931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the molecular classification of pediatric brain tumors: a guide to the galaxy.
    Cacciotti C; Fleming A; Ramaswamy V
    J Pathol; 2020 Jul; 251(3):249-261. PubMed ID: 32391583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric brain tumors: the era of molecular diagnostics, targeted and immune-based therapeutics, and a focus on long term neurologic sequelae.
    Plant-Fox AS; O'Halloran K; Goldman S
    Curr Probl Cancer; 2021 Aug; 45(4):100777. PubMed ID: 34303558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interphase cytogenetics: a new tool for the study of genetic changes in brain tumors.
    Arnoldus EP; Wolters LB; Voormolen JH; van Duinen SG; Raap AK; van der Ploeg M; Peters AC
    J Neurosurg; 1992 Jun; 76(6):997-1003. PubMed ID: 1588436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploiting Laboratory Insights to Improve Outcomes of Pediatric Central Nervous System Tumors.
    Robinson GW; Witt H; Resnick A
    Am Soc Clin Oncol Educ Book; 2016; 35():e540-6. PubMed ID: 27249765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms and therapeutic targets in pediatric brain tumors.
    Liu KW; Pajtler KW; Worst BC; Pfister SM; Wechsler-Reya RJ
    Sci Signal; 2017 Mar; 10(470):. PubMed ID: 28292958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma.
    Huse JT; Holland EC
    Nat Rev Cancer; 2010 May; 10(5):319-31. PubMed ID: 20414201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic landscape of paired neurospheres and traditional monolayer cultures in pediatric malignant brain tumors.
    Zhao X; Zhao YJ; Lin Q; Yu L; Liu Z; Lindsay H; Kogiso M; Rao P; Li XN; Lu X
    Neuro Oncol; 2015 Jul; 17(7):965-77. PubMed ID: 25537021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial gliomas: report of four families, with chromosome studies.
    Chadduck WM; Netsky MG
    Neurosurgery; 1982 Apr; 10(4):445-9. PubMed ID: 6285217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic alterations in glioma and medulloblastoma.
    Rasheed BK; Bigner SH
    Cancer Metastasis Rev; 1991 Dec; 10(4):289-99. PubMed ID: 1786630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances on Epigenetic Drugs for Pediatric Brain Tumors.
    Skouras P; Markouli M; Strepkos D; Piperi C
    Curr Neuropharmacol; 2023; 21(7):1519-1535. PubMed ID: 36154607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogene amplification in pediatric brain tumors.
    Wasson JC; Saylors RL; Zeltzer P; Friedman HS; Bigner SH; Burger PC; Bigner DD; Look AT; Douglass EC; Brodeur GM
    Cancer Res; 1990 May; 50(10):2987-90. PubMed ID: 2334901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive high-resolution genomic profiling and cytogenetics of two pediatric and one adult medulloblastoma.
    Holland H; Xu LX; Ahnert P; Kirsten H; Koschny R; Bauer M; Schober R; Meixensberger J; Krupp W
    Pathol Res Pract; 2013 Sep; 209(9):541-7. PubMed ID: 23896263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosomal characteristics of neurogenic tumours in adults.
    Mark J
    Hereditas; 1971; 68(1):61-100. PubMed ID: 4376136
    [No Abstract]   [Full Text] [Related]  

  • 16. A molecular fingerprint for medulloblastoma.
    Lee Y; Miller HL; Jensen P; Hernan R; Connelly M; Wetmore C; Zindy F; Roussel MF; Curran T; Gilbertson RJ; McKinnon PJ
    Cancer Res; 2003 Sep; 63(17):5428-37. PubMed ID: 14500378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant brain tumors: two steps forward.
    Puget S; Rutka JT
    Clin Neurosurg; 2007; 54():4-9. PubMed ID: 18504889
    [No Abstract]   [Full Text] [Related]  

  • 18. Class III beta-tubulin isotype: a key cytoskeletal protein at the crossroads of developmental neurobiology and tumor neuropathology.
    Katsetos CD; Legido A; Perentes E; Mörk SJ
    J Child Neurol; 2003 Dec; 18(12):851-66; discussion 867. PubMed ID: 14736079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental origins and oncogenic pathways in malignant brain tumors.
    Lu QR; Qian L; Zhou X
    Wiley Interdiscip Rev Dev Biol; 2019 Jul; 8(4):e342. PubMed ID: 30945456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using mice to decipher the molecular genetics of brain tumors.
    Hesselager G; Holland EC
    Neurosurgery; 2003 Sep; 53(3):685-94; discussion 695. PubMed ID: 12943584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.